LPDX Insider Trading Activity and SEC Form 4 Filings
LPDX insider trading summary
No open-market insider purchases or sales of Liposcience Inc (LPDX) have been reported on SEC Form 4 in the past 12 months.
Latest LPDX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 4, 2013 | Daniel J Levangie | Director | Buy | $42K (10,000 @ $4.17) |
| Dec 4, 2013 | E. Duffy McDonald | Vice President, HR | Sell | $52K (12,731 @ $4.07) |
| Nov 25, 2013 | James R Hurley | Director | Buy | $20K (5,100 @ $3.91) |
| Nov 18, 2013 | Robert J Greczyn Jr | Interim CEO | Buy | $24K (5,730 @ $4.15) |
| Nov 18, 2013 | Robert J Greczyn Jr | Interim CEO | Buy | $18K (4,270 @ $4.16) |
| Jan 30, 2013 | Tac Management LLC | 10% Owner | Buy | $1.8M (205,295 @ $9.00) |
| Jan 30, 2013 | Mark A Wan | 10% Owner | Buy | $1.8M (205,295 @ $9.00) |
| Jan 30, 2013 | Mark A Wan | 10% Owner | Buy | $87K (9,705 @ $9.00) |
| Jan 30, 2013 | Wilfred E Jaeger | 10% Owner | Buy | $87K (9,705 @ $9.00) |
| Jan 30, 2013 | Three Arch Capital LP | 10% Owner | Buy | $1.8M (205,295 @ $9.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.